Immunogenicity and safety of the third dose COVID-19 vaccine via intradermal compare with intramuscular administration (Randomized controlled trial)

Authors
Category Primary study
Registry of TrialsTCTR
Year 2021
This article has no abstract
Epistemonikos ID: 5f265e14f0cf8fc554318a568b7c4b10e9600c82
First added on: Oct 08, 2021